A veteran builder of strategic partnerships, teams and companies, with a deep background in genomics, diagnostics and oncology and a strong focus on creating long term value through collaboration.
Nurjana Bachman brings 15+ years of experience developing and managing strategic partnerships and is a people-oriented builder of companies and teams. She joined ROME after 6 years at Foundation Medicine, where she established and managed the team that led the company’s corporate partnerships, yielding 50+ companion diagnostic approvals in the US and Japan, and supporting several first-in-class therapeutic approvals in oncology. Prior to joining Foundation Medicine, she served as Chief Business Officer and Co-founder of Claritas Genomics and was responsible for corporate development and fund-raising. She was a key leader in development of the business model, strategic plan and vision for the company, and closed both Series A and B fundraising rounds with multiple strategic investors. Before Claritas, she served as Associate Director of Strategic Initiatives and Business Development at Boston Children’s Hospital, Technology and Innovation Development Office, partnering a diverse set of technologies with outside entities and initiating start-up company formation. Dr. Bachman earned a Ph.D. in molecular biology and genetics at The Johns Hopkins University School of Medicine, where she studied retrotransposition in the laboratory of Jef Boeke, Ph.D., and she holds a B.A. in biology with distinction from Swarthmore College.